References
- Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164(6): 942–8. [CrossRef]
- Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46(7): 894–921. [CrossRef]
- Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, et al. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder: proof-of-concept and proof-of- product studies. Arch Gen Psychiatry 2003; 60(2): 204–11. [CrossRef]
- Katzman MA, Sternat T. A Review of OROS methylphenidate (Concerta®) in the treatment of attention-deficit/hyperactivity disorder. CNS Drugs 201; 28(11): 1005–33. [CrossRef]
- White SR, Yadao CM. Characterization of methylphenidate exposures reported to a regional poison control centre. Arch Pediatr Adolesc Med 2000; 154(12): 1199–203. [CrossRef]
- Klampf K, Quattländer A, Burger R, Pfuhlmann B, Warnke A, Gerlach M. Case report: intoxication with high dose of long-acting methylphenidate (Concerta®) in a suicidal 14-year- old girl. Atten Defic Hyperact Disord 2010; 2(4): 221–4. [CrossRef]
- Scharman EJ, Erdman AR, Cobaugh DJ, Olson KR, Woolf AD, Caravati EM. et al. American Association of Poison Control Centers. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2007; 45(7): 737–52. [CrossRef]
- Spiller HA, Hays HL, Aleguas A Jr. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs 2013; 27(7): 531–43. [CrossRef]
- Klein-Schwartz W. Abuse and toxicity of methylphenidate. Curr Opin Pediatr 2002; 14(2): 219–23. [CrossRef]
- Eryilmaz G, Gul IG, Yorbik O, Isiten N. Long-acting methylphenidate toxicity: a case report. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2014; 24(4): 384–6. [CrossRef]
- Ozdemir E, Karaman MG, Yurteri N, Erdogan A. A case of suicide attempt with long-acting methylphenidate (Concerta). Atten Defic Hyperact Disord 2010; 2(3): 103–5. [CrossRef]